News
-
-
-
-
PRESS RELEASE
DEAG fully on track with very good organic business development in 2023 – Detlef Kornett named sole CEO of DEAG
DEAG reports strong financial performance in 2023; Detlef Kornett named sole CEO. Revenue approx. EUR 313 million. EBITDA approx. EUR 31 million. Buy-and-build strategy successful -
PRESS RELEASE
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap, with a target price of €3.20 and a potential upside of 87% according to the study 'Du baume au coeur'. The coverage adds to the financial analyst consensus -
-
-
-
-